BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19793612)

  • 61. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
    Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Mahfouz RA; Hamadani M
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1006-12. PubMed ID: 23396213
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ; Paterakis G
    Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients.
    Guolo F; Minetto P; Clavio M; Marcolin R; Miglino M; Passannante M; Caviglia F; Ballerini F; Tedone E; Kunkl A; Mangerini R; Contini P; Colombo N; Cagnetta A; Cea M; Carminati E; Pugliese G; Gobbi M; Lemoli RM
    Leuk Lymphoma; 2020 Jul; 61(7):1695-1701. PubMed ID: 32186422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
    Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
    Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.
    Petrella T; Hervé G; Bonnotte B; Girodon F; Carlson JA; Bour JB; Lebon P; Mugneret F; Callier P
    Am J Dermatopathol; 2012 Aug; 34(6):626-31. PubMed ID: 22534638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Plasmacytoïd dendritic cells acute leukemia: a case report].
    Bousquet A; Doutrelon C; Konopacki J; Marfaing-Koka A; Segot A; Martinaud C; Samson T; Souleau B; Malfuson JV; De Revel T; Foissaud V
    Ann Biol Clin (Paris); 2012 Oct; 70(5):617-21. PubMed ID: 23047909
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion.
    Awasthi NP; Qayoom S; Dabadghao S
    J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.
    Tokuda K; Eguchi-Ishimae M; Yagi C; Kawabe M; Moritani K; Niiya T; Tauchi H; Ishii E; Eguchi M
    Genes Chromosomes Cancer; 2014 Jan; 53(1):78-89. PubMed ID: 24142740
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
    Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.
    Bénet C; Gomez A; Aguilar C; Delattre C; Vergier B; Beylot-Barry M; Fraitag S; Carlotti A; Dechelotte P; Hospital V; d'Incan M; Costes V; Dereure O; Ortonne N; Bagot M; Laroche L; Blom A; Dalac S; Petrella T
    Am J Clin Pathol; 2011 Feb; 135(2):278-90. PubMed ID: 21228369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
    Dalle S; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dompmartin A; d'Incan M; Maubec E; Grange F; Dereure O; Prey S; Barete S; Wetterwald M; Fraitag S; Petrella T
    Br J Dermatol; 2010 Jan; 162(1):74-9. PubMed ID: 19689477
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
    Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
    Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
    Peng J; He S; Yang X; Huang L; Wei J
    Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
    Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
    Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary.
    Pileri A; Delfino C; Grandi V; Agostinelli C; Pileri SA; Pimpinelli N
    G Ital Dermatol Venereol; 2012 Dec; 147(6):603-8. PubMed ID: 23149706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Blastic plasmacytoid dendritic cell neoplasm variant acute leukemia: case report].
    Flores-Angulo C; Chona Z; Sánchez MA; Salazar M; Hennig H
    Rev Peru Med Exp Salud Publica; 2019; 36(2):353-359. PubMed ID: 31460652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.